FDA eases review burden for certain sutures, orthopedic devices in leap-frog guidances

Two new guidances using the US Food and Drug Administration’s (FDA) safety and performance-based pathway make it easier for less complex sutures and orthopedic devices to get to market. The guidances will enable sponsors to get their products cleared by demonstrating that a new product performs as well as its predicate.